<Record>
<Term>Recombinant Fowlpox-gp100p209</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<SemanticType>Virus</SemanticType>
<ParentTerm>Fowlpox Virus Vaccine</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Biological Response Modifier/Vaccine/Recombinant Viral Vaccine/Fowlpox Virus Vaccine/Recombinant Fowlpox-gp100p209</ClassificationPath>
<BroaderTerm>Recombinant Fowlpox-gp100p209</BroaderTerm>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Fowlpox Virus Vaccine</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Recombinant Viral Vaccine</BroaderTerm>
<BroaderTerm>Biological Response Modifier</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<BroaderTerm>Vaccine</BroaderTerm>
<Synonym>Recombinant Fowlpox-gp100p209</Synonym>
<Synonym>rF-gp100p209</Synonym>
<Description>A viral vaccine comprised of a recombinant fowlpox vector construct encoding a modified epitope of the melanoma antigen glycoprotein 100 (gp100), ES-2092M(gp100), containing an endoplasmic reticulum signal sequence targeted to the endoplasmic reticulum apparatus. Vaccination with recombinant fowlpox-gp100p209 vaccine may stimulate the host immune system more efficiently to mount a cytotoxic T lymphocyte response against tumor cells expressing the gp100 antigen.</Description>
<Source>NCI Thesaurus</Source>
</Record>
